| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
10,480 |
3,415 |
$884K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,502 |
3,432 |
$254K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,154 |
3,975 |
$82K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
931 |
918 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
266 |
261 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
348 |
318 |
$14K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
95 |
94 |
$13K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
368 |
357 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
343 |
296 |
$11K |
| 87428 |
|
85 |
74 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
154 |
148 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
669 |
637 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38 |
37 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
16 |
$723.68 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
27 |
$521.17 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
102 |
96 |
$414.94 |
| 99051 |
|
20 |
20 |
$68.60 |
| 87081 |
|
12 |
12 |
$55.80 |
| S9083 |
Global fee urgent care centers |
15 |
13 |
$0.00 |